Longevity

March 14, 2019
Published by admin_auro at March 14, 2019
Categories

Ribonucleic acid-based Lifespan extension therapy: A therapeutic mix encompassing lncRNA-TUG1 and/or Ursolic acid, Maresin, DIM, Ursolic acid  Lutein, Maresin, Cholecalciferol, Catalpol, Isoliquiritigenin (UMDULMCCI)  activates autophagy, promotes leanness, increases insulin sensitivity, improves motor function, alleviates ageing feature and extends lifespan via upregulation of its target gene ATG5 (Autophagy-related 5), 14/March/2018, 11.01 pm

Introduction: What they say A study from the Global Research Laboratory, Seoul National University, Korea shows that “Overexpression of Atg5 in mice activates autophagy and extends lifespan.” This study was […]
Do you like it?0
Read more
March 4, 2019
Published by admin_auro at March 4, 2019
Categories

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA OIP5-AS1  inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 4/March/2019, 11.03 am

Introduction: What they say OIP5AS1- A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]
Do you like it?0
Read more
March 3, 2019
Published by admin_auro at March 3, 2019
Categories

Ribonucleic acid-based therapy for inflammation and arthritis:  LncRNA ZFAS1 (zinc finger antisense (ZFAS)1 increases IL-9 levels, augments proliferation of ILC2s (type 2 innate lymphoid cells) and regulatory T (Treg) cells, promotes resolution of inflammation, attenuates cartilage destruction, decreases bone loss, and inhibits pathological features associated with arthritis via up-regulation of its target genes, 3/March/2018, 9.13 am

Introduction: What they say A study from Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany shows that […]
Do you like it?0
Read more
March 3, 2019
Published by admin_auro at March 3, 2019
Categories

Ribonucleic acid-based therapy for aging-associated diseases and Lifespan extension: LncRNA CCAT1  inhibits the interaction of DBC1 with PARP1, increases the PARP1 activity, promotes DNA repair, augments tolerance against radiation, cancer, and aging, via down-regulation of its target gene, 3/March/2019, 8.50 am

Introduction: What they say A study from Department of Genetics, Paul F. Glenn Center for the Biology of Aging, Harvard Medical School, Boston, MA, USA; and […]
Do you like it?0
Read more
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475
Next page